DK165833C - Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner - Google Patents

Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner

Info

Publication number
DK165833C
DK165833C DK422583A DK422583A DK165833C DK 165833 C DK165833 C DK 165833C DK 422583 A DK422583 A DK 422583A DK 422583 A DK422583 A DK 422583A DK 165833 C DK165833 C DK 165833C
Authority
DK
Denmark
Prior art keywords
nonanes
diazabicyclo
preparation
analogy procedure
substituents
Prior art date
Application number
DK422583A
Other languages
Danish (da)
English (en)
Other versions
DK165833B (da
DK422583A (da
DK422583D0 (da
Inventor
Uwe Schoen
Bernd Hachmeister
Wolfgang Kehrbach
Ulrich Kuehl
Gerd Buschmann
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of DK422583D0 publication Critical patent/DK422583D0/da
Publication of DK422583A publication Critical patent/DK422583A/da
Publication of DK165833B publication Critical patent/DK165833B/da
Application granted granted Critical
Publication of DK165833C publication Critical patent/DK165833C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK422583A 1982-09-18 1983-09-16 Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner DK165833C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane
DE3234697 1982-09-18

Publications (4)

Publication Number Publication Date
DK422583D0 DK422583D0 (da) 1983-09-16
DK422583A DK422583A (da) 1984-03-19
DK165833B DK165833B (da) 1993-01-25
DK165833C true DK165833C (da) 1993-06-21

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK422583A DK165833C (da) 1982-09-18 1983-09-16 Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner

Country Status (25)

Country Link
US (2) US4550112A (el)
EP (2) EP0250903B1 (el)
JP (2) JPS5970686A (el)
AT (2) ATE69817T1 (el)
AU (1) AU564910B2 (el)
CA (1) CA1254209A (el)
CS (1) CS389891A3 (el)
DD (1) DD213923A5 (el)
DE (3) DE3234697A1 (el)
DK (1) DK165833C (el)
ES (1) ES525653A0 (el)
FI (1) FI76338C (el)
GE (1) GEP19960316B (el)
GR (1) GR78722B (el)
HU (1) HU191096B (el)
IE (1) IE57580B1 (el)
IL (1) IL69751A (el)
MX (1) MX9202996A (el)
NO (1) NO160516C (el)
NZ (1) NZ205627A (el)
PH (1) PH20768A (el)
PT (1) PT77344B (el)
SU (1) SU1272989A3 (el)
UA (1) UA817A1 (el)
ZA (1) ZA836185B (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) * 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
AU2004260624A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AR057064A1 (es) * 2005-06-13 2007-11-14 Astrazeneca Ab Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (el) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
NO160516B (no) 1989-01-16
DK165833B (da) 1993-01-25
DE3382466D1 (de) 1992-01-09
EP0250903A2 (de) 1988-01-07
ATE45579T1 (de) 1989-09-15
JPS5970686A (ja) 1984-04-21
DD213923A5 (de) 1984-09-26
US4550112A (en) 1985-10-29
ES8405398A1 (es) 1984-06-01
ATE69817T1 (de) 1991-12-15
JPH05247039A (ja) 1993-09-24
NO160516C (no) 1989-04-26
IE57580B1 (en) 1993-01-13
CA1254209A (en) 1989-05-16
IL69751A (en) 1986-10-31
EP0103833A3 (en) 1984-11-28
DK422583A (da) 1984-03-19
CA1259998C (el) 1989-09-26
SU1272989A3 (ru) 1986-11-23
IE832186L (en) 1984-03-18
US4742172A (en) 1988-05-03
AU1920683A (en) 1984-03-22
NO833346L (no) 1984-03-19
IL69751A0 (en) 1983-12-30
NZ205627A (en) 1985-11-08
GEP19960316B (en) 1996-06-24
FI833339A (fi) 1984-03-19
DE3380409D1 (de) 1989-09-21
UA817A1 (uk) 1993-12-15
AU564910B2 (en) 1987-09-03
GR78722B (el) 1984-10-02
PH20768A (en) 1987-04-10
DE3234697A1 (de) 1984-03-22
PT77344A (en) 1983-10-01
ES525653A0 (es) 1984-06-01
PT77344B (en) 1986-03-11
FI76338C (fi) 1988-10-10
ZA836185B (en) 1984-04-25
EP0250903B1 (de) 1991-11-27
EP0250903A3 (en) 1988-03-09
EP0103833B1 (de) 1989-08-16
MX9202996A (es) 1992-07-01
FI833339A0 (fi) 1983-09-19
EP0103833A2 (de) 1984-03-28
JPH0670056B2 (ja) 1994-09-07
FI76338B (fi) 1988-06-30
CS389891A3 (en) 1992-07-15
HU191096B (en) 1987-01-28
DK422583D0 (da) 1983-09-16

Similar Documents

Publication Publication Date Title
DK165833C (da) Analogifremgangsmaade til fremstilling af diazabicyclo-(3,3,1)-nonaner
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
IL69659A (en) 6-(2-(cyclic amino)ethylamino)tetrahydrotriazolo(3,4-a)phthalazines,their preparation and pharmaceutical compositions containing them
ATE11545T1 (de) Gesaettigte aminocyclitderivate, ihre herstellung und sie enthaltende arzneimittel.
DK149270C (da) Analogifremgangsmaade til fremstilling af beta-carbolin-3-carboxylsyrederivater
ATE70060T1 (de) Neue tetrahydro-benzothiazole, ihre herstellung und verwendung.
ATE67186T1 (de) 3-methylphthalimide.
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
DE2962503D1 (en) Imidazo (1,2-a) imidazoles, their acid addition salts, medicaments containing them and process for their preparation
MX9101659A (es) Derivados de ergolina, proceso para su produccion y composicion farmaceutica que los contiene.

Legal Events

Date Code Title Description
PUP Patent expired